304 related articles for article (PubMed ID: 18789928)
1. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts.
Bock F; Onderka J; Hos D; Horn F; Martus P; Cursiefen C
Exp Eye Res; 2008 Nov; 87(5):462-70. PubMed ID: 18789928
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
Hos D; Bachmann B; Bock F; Onderka J; Cursiefen C
Exp Eye Res; 2008 Nov; 87(5):427-32. PubMed ID: 18755186
[TBL] [Abstract][Full Text] [Related]
3. The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages.
Maruyama K; Nakazawa T; Cursiefen C; Maruyama Y; Van Rooijen N; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3145-53. PubMed ID: 22511631
[TBL] [Abstract][Full Text] [Related]
4. VesselJ: A New Tool for Semiautomatic Measurement of Corneal Neovascularization.
Rabiolo A; Bignami F; Rama P; Ferrari G
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8199-206. PubMed ID: 26720472
[TBL] [Abstract][Full Text] [Related]
5. Additional parameters for the morphometry of angiogenesis and lymphangiogenesis in corneal flat mounts.
Blacher S; Detry B; Bruyère F; Foidart JM; Noël A
Exp Eye Res; 2009 Aug; 89(2):274-6. PubMed ID: 19285069
[No Abstract] [Full Text] [Related]
6. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
Bock F; Onderka J; Dietrich T; Bachmann B; Kruse FE; Paschke M; Zahn G; Cursiefen C
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2545-52. PubMed ID: 17525183
[TBL] [Abstract][Full Text] [Related]
7. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
[TBL] [Abstract][Full Text] [Related]
9. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.
Cursiefen C; Maruyama K; Jackson DG; Streilein JW; Kruse FE
Cornea; 2006 May; 25(4):443-7. PubMed ID: 16670483
[TBL] [Abstract][Full Text] [Related]
10. Clinical and experimental research of corneal lymphangiogenesis after keratoplasty.
Ling S; Lin H; Xiang D; Feng G; Zhang X
Ophthalmologica; 2008; 222(5):308-16. PubMed ID: 18617753
[TBL] [Abstract][Full Text] [Related]
11. Netrin-4 Mediates Corneal Hemangiogenesis but Not Lymphangiogenesis in the Mouse-Model of Suture-Induced Neovascularization.
Maier AB; Klein S; Kociok N; Riechardt AI; Gundlach E; Reichhart N; Strauß O; Joussen AM
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1387-1396. PubMed ID: 28253401
[TBL] [Abstract][Full Text] [Related]
12. Corneal lymphangiogenesis: implications in immunity.
Patel SP; Dana R
Semin Ophthalmol; 2009; 24(3):135-8. PubMed ID: 19437348
[TBL] [Abstract][Full Text] [Related]
13. Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah Folkman.
Regenfuss B; Bock F; Parthasarathy A; Cursiefen C
Lymphat Res Biol; 2008; 6(3-4):191-201. PubMed ID: 19093792
[TBL] [Abstract][Full Text] [Related]
14. Regression of mature lymphatic vessels in the cornea by photodynamic therapy.
Bucher F; Bi Y; Gehlsen U; Hos D; Cursiefen C; Bock F
Br J Ophthalmol; 2014 Mar; 98(3):391-5. PubMed ID: 24414403
[TBL] [Abstract][Full Text] [Related]
15. An improved procedure to quantify tumour vascularity using true colour image analysis. Comparison with the manual hot-spot procedure in a human melanoma xenograft model.
van der Laak JA; Westphal JR; Schalkwijk LJ; Pahlplatz MM; Ruiter DJ; de Waal RM; de Wilde PC
J Pathol; 1998 Feb; 184(2):136-43. PubMed ID: 9602703
[TBL] [Abstract][Full Text] [Related]
16. A novel flow cytometry based assay for quantification of corneal angiogenesis in the mouse model of herpetic stromal keratitis.
Biswas PS; Banerjee K; Kim B; Smith J; Rouse BT
Exp Eye Res; 2005 Jan; 80(1):73-81. PubMed ID: 15652528
[TBL] [Abstract][Full Text] [Related]
17. Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation.
Bachmann BO; Luetjen-Drecoll E; Bock F; Wiegand SJ; Hos D; Dana R; Kruse FE; Cursiefen C
Br J Ophthalmol; 2009 Aug; 93(8):1075-80. PubMed ID: 19224901
[TBL] [Abstract][Full Text] [Related]
18. Cellular-level characterization of lymph vessels in live, unlabeled corneas by in vivo confocal microscopy.
Peebo BB; Fagerholm P; Traneus-Röckert C; Lagali N
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):830-5. PubMed ID: 19797212
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
Hos D; Bock F; Dietrich T; Onderka J; Kruse FE; Thierauch KH; Cursiefen C
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1836-42. PubMed ID: 18436817
[TBL] [Abstract][Full Text] [Related]
20. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.
Bock F; Onderka J; Dietrich T; Bachmann B; Pytowski B; Cursiefen C
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):115-9. PubMed ID: 17909835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
